中草药及化学成分对细胞色素CYP3A4影响的研究概况

1、中草药及化学成分对细胞色素CYP3A4影响的研究概况【摘要】目的介绍中草药化学成分对细胞色素P3A4亚型影响。方法查阅国内外近年来关于中草药化学成分对细胞色素YP3A4亚型影响的有关文献并进展综述。结果多种中草药及成分可以抑制或诱导细胞色素YP3A4亚型，从而影响合用药物的代谢，导致药物互相作用的发生甚至不良反响的发生。结论应重视一些中草药配伍其它药物对细胞色素YP3A4亚型的影响及所引起的药物互相作用和形成机制的研究，促进临床合理用药，进步中草药的有效性和平安性。【关键词】细胞色素P450酶；中草药；药物互相作用；合理用药Abstrat：bjetiveTintrduetheeffetfhei

2、alinstituentsfrhineseherbalediinenYP3A4isfrfythreP450syste.ethdsTsuarizerelatedliteratureabuthineseherbalediinenYP3A4isfrfythreP450systeinreentyearsatheandabrad.ResultsSehineseherbalediineanreduerindueYP3A4isfrfythreP450.nsequentlyitaffetedbineddrugetablisandresultedindruginteratin.nlusineshuldpayat

3、tentinttheeffetfsehineseherbalediinenYP3A4isfrfythreP450systeandrrespndingdruginteratinandtherrelatedehanis，inrdertensuretheeffiienyandsafetyfhineseherbalediine.Keyrds：ythreP450(YP);hineseherbalediine;Druginteratin;Ratinalusefediine美国的一项研究说明，住院患者的严重不良反响发生率为67，因药物互相作用的致死率已排名住院患者死亡原因的第45位。理解不同药物对代谢酶的调

4、节及预测可能的代谢性药物互相作用，并以体外研究所得数据为进一步的临床试验设计提供有价值的信息，降低临床试验的本钱及风险，防止因药物代谢性互相作用而引起的不良反响的发生。中药化学成分复杂，它的成分代谢多数情况下是通过细胞色素P450酶(YP)代谢同时可以抑制或诱导YP活性发生改变。人类细胞色素P450(YP450)是存在于肝脏微粒体混合功能氧化酶系的主要成分。我们综述了药物体外代谢研究试验中不用中药及化学成分对P3A4的影响，指导临床合理用药和中西药物互相作用研究中的应用。1中草药对YP3A4的影响中药配伍理论研究中，因为中药强调合并用药，方剂以复方为主，含有多种中药，因此中药配伍存在与P450

5、酶有关的中药间互相作用的时机可能更多;同时中药不管其成分多么复杂，但在体内起作用的物质根底仍然属于化合物范畴，既然是化合物，那么同样面临着机体对其的处置即P450酶的代谢。这样中药配伍就符合基于药物代谢酶产生药物互相作用的两个根本要素，即药物对P450酶产生影响，进一步受到影响的P450酶再作用于药物，改变药物的代谢特征，这就是基于P450酶的药物互相作用的分子基矗基于这种推论，我们对影响YP3A4作用的中药进展总结。见表1。表1中草药对YP3A4的影响略2中草药化学成分对YP3A4的影响中药同西药相比向来被认为使用平安，不良反响少，但由于中药所含的化学成分复杂，因此对酶的影响更具多样性，所以

6、对中草药成分对YP3A4的影响进展总结。见表2。表2中草药化学成分对YP3A4的影响略通过对作用于细胞色素YP3A4的中草药和化学成分总结，将会为临床中药物配伍提供参考，减少毒副作用，进步用药平安。【参考文献】1岩城正宏.各种未成熟柑橘类果实对YP3A4及P-糖蛋白活性的影响J.国际中医中药杂志,2022,28(6):365.2Subehan,UsiaT,IataH,etal.ehanis-basedinhibitinfYP3A4andYP2D6byIndnesianediinalplantsJ.J.Ethnpharal.,2022,105(3):449.3VenkataraananR,Raa

7、handranV,KrskiBJ,eta1,ilkthistle,aherbalsuppleent,dereasestheativityfYP3A4anduridinediphsphgluurnsyltransferaseinhuanhepatyteulturesJ.Drugetab.Disps.,2000,28(11):1270.4Palini,PzzettiL,SapneA,eta1.EffetflirieandglyyrrhizinnurineliverYP-dependentnxy-genasesJ.LifeSi.,1998,62(6):571.5BudzinskiJ,FsterB,V

8、andenhekS,etal.AninvitrevaluatinfhuanythreP4503A4inhibitinbyseletederialherbalextratsandtinturesJ.Phytediine,2000,74:273.6PekthngD,artinH,Abadie,etal.DifferentialinhibitinfratandhuanhepatiythreP450byAndrgraphispaniulataextratandandrgraphlideJ.J.Ethnpharal.,2022,115(3):432.7贾敬亮，徐丽娜，杜金粱，等.连翘苷对原代大鼠肝细胞Y

9、P3A1的影响J.黑龙江畜牧兽医,2022,10:84.8石井贤二,等.抑制YP3A4活性的绿茶成分J.国际中医中药杂志,2022,28(1):49.9FanL,angG,angLS,etal.HerbalediineYinZhiHuanginduesYP3A4-ediatedsulfxidatinandYP219-dependenthydrxylatinfeprazleJ.AtaPharalSin,2022,28(10):1685.10UhidaS,YaadaH,LiXD,etal.EffetsfGinkgBilbaExtratnPharakinetisandPharadynaisfTlbu

10、taideandidazlainHealthyVlunteersJ.JlinPharal,2022,46(11):1290.11LiuKH,KiJ,JenBH,ShnJH,etal.InhibitinfhuanythreP450isfrsandNADPH-YPredutaseinvitrby15herbalediines,inludingEpiediiherbaJ.J.lin.Phar.Ther.,2022,31(1):83.12AndersnGD,RsitG,hustsyA,etal.DruginteratinptentialfsyextratandPanaxginsengJ.J.lin.P

11、haral.,2022,43(6):643.13HelluBH,NilsenG.InvitrinhibitinfYP3A4etablisandP-glyprtEin-ediatedtransprtbytradeherbalprdutsJ.Basi.lin.Pharal.Txil.,2022,102(5):466.14岩城正宏.各种未成熟柑橘类果实对YP3A4及P-糖蛋白活性的影响J.国际中医中药杂志,2022,28(6):365.15董海燕,邵敬伟,王涛,等.四种抗癌中药提取物对大鼠肝YP3A酶活性及RNA表达的影响J.中药材,2022,31(1):68.16UsiaT,IataH,Hirat

12、sukaA,etal.YP3A4andYP2D6inhibitryativitiesfIndnesianediinalplantsJ.Phytediine,2022,13(1-2):67.17IataH,TezukaY,KadtaS,etal.etablis-dependentinhibitinfYP3A4andYP2D6byextratsfr26herbalediinesJ.J.Trad.ed.,2022,21(6):281.18IataH,TezukaY,UsiaT,etal.InhibitinfhuanliverirsalYP3A4andYP2D6byextratsfr78herbale

13、diinesJ.J.Trad.ed.,2022,21(1):42.19Subehan,ZaidiSF,KadtaS,etal.InhibitinnhuanliverythreP4503A4bynstituentsffennel(Feniuluvulgare):identifiatinandharaterizatinfaehanis-basedinativatrJ.J.Agri.Fdhe.,2022,55(25):10162.转贴于论文联盟.ll.20PiverB,BerthuF,DreanY,etal.InhibitinfYP3A,YP1AandYP2E1ativitiesbyresverat

14、rlandthernnvlatileredinepnentsJ.Txil.Lett.,2001,125(1-3):83.21Yu,YeS,SunH,LiuY,etal.PXR-ediatedtransriptinalativatinfYP3A4byrypttanshinneandtanshinneIIAJ.he.Bil.Interat.2022,177(1):58.22SubehanS,KadtaS,TezukaY.Invitrehanis-basedinativatinfythreP4503A4byanenstituentfinnauburaniJ.Planta.ed.,2022,74(12

15、):1474.23GirennavarB,JayaprakashaGK,PatilBS.PtentinhibitinfhuanythreP4503A4,2D6,and29isenzyesbygrapefruitjuieanditsfuruarinsJ.J.FdSi.,2022,72(8):417.24HP,SavilleDJ,anilrukS.InhibitinfhuanYP3A4ativitybygrapefruitflavnids,furanuarinsandrelatedpundsJ.J.Phar.Phar.Si.,2001,4(3):217.25TsukatS,Aburatani,Ys

16、hidaT,etal.YP3A4inhibitrsislatedfrLirieJ.Bil.Phar.Bull.,2022,28(10):2000.26TsukatS,Aburatani,YshidaT,etal.YP3A4inhibitrsislatedfrLirieJ.Bil.Phar.Bull.,2022,28(10):2000.27LeeJY,DukeRK,TranVH,etal.HyperfrinanditsanalguesinhibitYP3A4enzyeativityJ.Phytheistry,2022,67(23):2550.28HendersnGL,HarkeyR,Gershi

17、nE,etal.Effetsfginsengpnentsn-DNA-expressedythreP450enzyeatalytiativityJ.LifeSi.,1999,65(15):PL209.29BhardajRK,GlaeserH,BequentL,etal.Piperine,aajrnstituentfblakpepper,inhibitshuanP-glyprtEinandYP3A4J.J.Pharal.Exp.Ther.,2002,302(2):645.30Subehan,UsiaT,KadtaS,etal.nstituentsfZingiberaratiuandthEIrYP3

18、A4andYP2D6inhibitryativityJ.he.Phar.Bull.(Tky),2022,53(3):333.31DreiseitelA,ShreierP,eheA,etal.AnthyaninsandtheiretablitesareeakinhibitrsfythreP4503A4J.l.Nutr.FdRes.,2022,52(12):1428.32SinghYN.PtentialfrinteratinfkavaandSt.JhnsrtithdrugsJ.J.Ethnpharal.,2022,100(1-2):108.33Appiah-pngR,andeurJN,vanVug

19、t-LussenburgB,etal.InhibitinfhuanrebinantythreP450sbyuruinanduruindepsitinprdutsJ.Txilgy,2022,235(1-2):83.34hHH,HakiIA,ViningDR,etal.EffetsfrepeatedgreenteaatehinadinistratinnhuanythreP450ativityJ.anerEpideil.BiarkersPrev.,2022,15(12):2473.35Ganzera,ShneiderP,StuppnerH.Inhibitryeffetsftheessentialil

20、fhaile(atriariareutitaL.)anditsajrnstituentsnhuanythreP450enzyesJ.LifeSi.,2022,78(8):856.36TakahashiE,FujitaK,KaatakiT,etal.InhibitinfhuanythreP4501B1,1A1and1A2byantigentxipunds,purpurinandalizarinJ.utat.Res.,2002,508(1-2):147.37JulsingK,VasilevNP,Shneidan-DuhvnyD,etal.etablistereseletivityfythreP45

21、03A4tardsdexypdphylltxin:InsilipreditinsandexperientalvalidatinJ.Eur.J.ed.he.,2022,43(6):1171.38HeN,EdekiT.TheinhibitryeffetsfherbalpnentsnYP29andYP3A4atalytiativitiesinhuanliverirsesJ.A.J.Ther.,2022,11(3):206.39LiuY,aH,ZhangJ,etal.InfluenefginsensideRh1andF1nhuanythrep450enzyesJ.Planta.ed.,2022,72(

22、2):126.40HendersnGL,HarkeyR,GershinE,etal.Effetsfginsengpnentsn-DNA-expressedythreP450enzyeatalytiativityJ.LifeSi.,1999,65(15):PL209.41Subehan,ZaidiSF,KadtaS,etal.InhibitinnhuanliverythreP4503A4bynstituentsffennel(Feniuluvulgare):identifiatinandharaterizatinfaehanis-basedinativatrJ.J.Agri.Fdhe.,2022

23、,55(25):10162.42Appiah-pngR,andeurJN,vanVugt-LussenburgB,etal.InhibitinfhuanrebinantythreP450sbyuruinanduruindepsitinprdutsJ.Txilgy,2022,235(1-2):83.43ZhangFF,ZhengYF,ZhuHJ,etal.Effetsfkaepferlandqueretinnythre450ativitiesinpriarilyulturedrathepatytesJ.ZhejiangDaXueXueBaYiXueBan,2022,35(1):18.44Usia

24、T,atabeT,KadtaS,etal.ehanis-basedinhibitinfYP3A4bynstituentsfZingiberaratiuJ.Bil.Phar.Bull.,2022,28(3):495.45TsukatS,TiseK,Aburatani,etal.IslatinfythreP450inhibitrsfrstraberryfruit,FragariaananassaJ.J.Nat.Prd.,2022,67(11):1839.46FuhrU,Bekann-KnppS,JetterA,etal.Theeffetfsilyarinnralnifedipinepharakin

25、etisJ.Planta.ed.,2022,73(14):1429.47hatterjeeP,FranklinR.Huanythrep450inhibitinandetabli-interediateplexfratinbygldensealextratanditsethylenedixyphenylpnentsJ.Drugetab.Disps.,2022,31(11):1391.48LiL,StantnJD,TlsnAH,etal.BiativeTerpenidsandFlavnidsfrGinkgBilbaExtratInduetheExpressinfHepatiDrug-etabliz

26、ingEnzyesthrughPregnaneXReeptr,nstitutiveAndrstaneReeptr,andArylhydrarbnReeptr-ediatedPathaysJ.Phar.Res.,2022,26(4)：872.49QiuF,ZhangR,SunJetal.InhibitryeffetsfsevenpnentsfdanshenextratnatalytiativityfythreP450enzyeinhuanliverirsesJ.Drugetab.Disps.,2022,36(7):1308.50RE,BrnSA,StahulskiAV,etal.Design,s

27、ynthesisandevaluatinffuranuarinnersasinhibitrsfYP3A4J.rg.Bil.he.,2022,4(8):1604.51enYH,SahiJ,UrdaE,etal.Effetsfbergattinnhuanandnkeydrug-etablizingenzyesinpriaryulturedhepatytesJ.Drugetab.Disps.,2002,30(9):977.52FanL,angG,angLS,etal.HerbalediineYinZhiHuanginduesYP3A4-ediatedsulfxidatinandYP219-depen

28、denthydrxylatinfeprazleJ.AtaPharalSin,2022,28(10):1685.53Ganzera,ShneiderP,StuppnerH.Inhibitryeffetsftheessentialilfhaile(atriariareutitaL.)anditsajrnstituentsnhuanythreP450enzyesJ.LifeSi.,2022,78(8):856.54UsiaT,IataH,HiratsukaA,etal.SesquiterpenesandflavnlglysidesfrZingiberaratiuandtheirYP3A4andYP2D6inhibitr